-
-
-
-
-
-
-
Erasca reports early clinical responses for cancer drug ERAS-0015
-
-
-
-
-
-
-
Erasca, Inc (ERAS) Announces Clinical Trial Collaboration and Supply Agreement with Pierre Fabre to Evaluate ERAS-007 and Encorafenib Combination
-
-
66,735 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

